Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
227 INR | +0.07% | +5.70% | -25.14% |
Valuation
Fiscal Period: March | 2023 |
---|---|
Capitalization 1 | 545.1 |
Enterprise Value (EV) 1 | 551.5 |
P/E ratio | 13.6 x |
Yield | - |
Capitalization / Revenue | 1.91 x |
EV / Revenue | 1.93 x |
EV / EBITDA | 1,23,67,157 x |
EV / FCF | -2,85,05,766 x |
FCF Yield | -0% |
Price to Book | 2.02 x |
Nbr of stocks (in thousands) | 5,961 |
Reference price 2 | 91.45 |
Announcement Date | 11/09/23 |
Income Statement Evolution (Annual data)
Fiscal Period: March | 2021 | 2022 | 2023 |
---|---|---|---|
Net sales 1 | 65.52 | 134.9 | 286.1 |
EBITDA | - | 34.24 | 44.59 |
EBIT 1 | 1.269 | 34.22 | 43.69 |
Operating Margin | 1.94% | 25.37% | 15.27% |
Earnings before Tax (EBT) 1 | 1.267 | 34.21 | 42.58 |
Net income 1 | 0.9377 | 25.6 | 40.05 |
Net margin | 1.43% | 18.98% | 14% |
EPS 2 | 0.3663 | 10.00 | 6.720 |
Free Cash Flow | - | -4.945 | -19.35 |
FCF margin | - | -3.67% | -6.76% |
FCF Conversion (EBITDA) | - | - | - |
FCF Conversion (Net income) | - | - | - |
Dividend per Share | - | - | - |
Announcement Date | 17/01/23 | 17/01/23 | 11/09/23 |
Balance Sheet Analysis
Fiscal Period: March | 2021 | 2022 | 2023 |
---|---|---|---|
Net Debt 1 | 1.87 | 2.42 | 6.39 |
Net Cash position 1 | - | - | - |
Leverage (Debt/EBITDA) | - | 0.0706 x | 0.1433 x |
Free Cash Flow | - | -4.95 | -19.3 |
ROE (net income / shareholders' equity) | - | 189% | 27.1% |
ROA (Net income/ Total Assets) | - | 56.3% | 15.3% |
Assets 1 | - | 45.48 | 262.6 |
Book Value Per Share 2 | 0.2500 | 10.30 | 45.20 |
Cash Flow per Share 2 | 2.870 | 3.650 | 0.1900 |
Capex | - | 0.07 | 7.42 |
Capex / Sales | - | 0.05% | 2.6% |
Announcement Date | 17/01/23 | 17/01/23 | 11/09/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-25.14% | 1.62Cr | |
-16.17% | 214.95Cr | |
-1.95% | 191.04Cr | |
-27.29% | 116.9Cr | |
-12.77% | 96Cr | |
-5.06% | 79Cr | |
+20.07% | 74Cr | |
-3.83% | 60Cr | |
-5.62% | 49Cr | |
+2.28% | 44Cr |
- Stock Market
- Equities
- NIRMAN Stock
- Financials Nirman Agri Genetics Limited